Who benefits from medical interventions?
作者信息
Smith G D, Egger M
出版信息
BMJ. 1994 Jan 8;308(6921):72-4. doi: 10.1136/bmj.308.6921.72.
Abstract
摘要
相似文献
1
Who benefits from medical interventions?
BMJ. 1994 Jan 8;308(6921):72-4. doi: 10.1136/bmj.308.6921.72.
2
Cardiovascular disease in diabetes.
Clin Evid. 2002 Jun(7):498-520.
3
Aspirin for primary prevention of cardiovascular disease (revisited).
Med Lett Drugs Ther. 2006 Jul 3;48(1238):53.
4
[Primary cardiovascular prevention with aspirin].
Semergen. 2015 Jul-Aug;41(5):279-81. doi: 10.1016/j.semerg.2014.12.004. Epub 2015 Jan 23.
5
Anti-platelet therapy: is it all over in peripheral artery disease?
Thromb Haemost. 2010 Apr;103(4):689-91. doi: 10.1160/TH10-01-0053. Epub 2010 Feb 19.
6
Aspirin resistance: myth or reality?
Indian Heart J. 2003 May-Jun;55(3):217-22.
7
Platelet inhibitors: what are the data in women?
Cardiol Rev. 2008 Jan-Feb;16(1):23-9. doi: 10.1097/CRD.0b013e31815a7e30.
8
[Expert consensus document on the use of antiplatelet agents].
Kardiologiia. 2004;44(3):75.
9
Cardiovascular disorders. Primary prevention.
Clin Evid. 2002 Jun(7):91-123.
10
Aggressive antiplatelet strategies: time to reconsider?
Eur Heart J. 2007 Sep;28(18):2183-4. doi: 10.1093/eurheartj/ehm326. Epub 2007 Aug 2.
引用本文的文献
1
Small Study Effects in Diagnostic Imaging Accuracy: A Meta-Analysis.
JAMA Netw Open. 2022 Aug 1;5(8):e2228776. doi: 10.1001/jamanetworkopen.2022.28776.
2
The effects of acupuncture on pregnancy outcomes of in vitro fertilization: a systematic review and meta-analysis.
BMC Complement Altern Med. 2019 Jun 14;19(1):131. doi: 10.1186/s12906-019-2523-7.
3
Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-Controlled Trials.
Adv Ther. 2019 May;36(5):1085-1099. doi: 10.1007/s12325-019-00921-w. Epub 2019 Mar 16.
4
Using group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence.
Int J Epidemiol. 2016 Dec 1;45(6):2184-2193. doi: 10.1093/ije/dyw125.
5
Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence.
PLoS One. 2013;8(3):e60009. doi: 10.1371/journal.pone.0060009. Epub 2013 Mar 26.
6
Three-armed trials including placebo and no-treatment groups may be subject to publication bias: systematic review.
PLoS One. 2011;6(5):e20679. doi: 10.1371/journal.pone.0020679. Epub 2011 May 31.
7
Multiple risk factor interventions for primary prevention of coronary heart disease.
Cochrane Database Syst Rev. 2011 Jan 19;2011(1):CD001561. doi: 10.1002/14651858.CD001561.pub3.
8
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
BMJ. 2010 Mar 23;340:c869. doi: 10.1136/bmj.c869.
9
Multiple risk factor interventions for primary prevention of coronary heart disease.
Cochrane Database Syst Rev. 2006 Oct 18(4):CD001561. doi: 10.1002/14651858.CD001561.pub2.
10
Explaining the social gradient in coronary heart disease: comparing relative and absolute risk approaches.
J Epidemiol Community Health. 2006 May;60(5):436-41. doi: 10.1136/jech.2005.041350.
本文引用的文献
1
Cholesterol lowering and mortality: the importance of considering initial level of risk.
BMJ. 1993 May 22;306(6889):1367-73. doi: 10.1136/bmj.306.6889.1367.
2
Management of raised blood pressure in New Zealand: a discussion document.
BMJ. 1993 Jul 10;307(6896):107-10. doi: 10.1136/bmj.307.6896.107.
3
Blood pressure management: individualized treatment based on absolute risk and the potential for benefit.
Ann Intern Med. 1993 Aug 15;119(4):329-35. doi: 10.7326/0003-4819-119-4-199308150-00013.
4
Cost effectiveness analysis of early zidovudine treatment of HIV infected patients.
BMJ. 1993 Nov 20;307(6915):1322-5. doi: 10.1136/bmj.307.6915.1322.
5
Preliminary analysis of the Concorde trial. Concorde Coordinating Committee.
Lancet. 1993 Apr 3;341(8849):889-90. doi: 10.1016/0140-6736(93)93096-j.
6
Attacks on heart diseases.
Lancet. 1993 Nov 20;342(8882):1291-2. doi: 10.1016/0140-6736(93)92375-4.
7
Sounding board. Risks of correcting the risks of coronary disease and stroke with drugs.
N Engl J Med. 1982 Feb 4;306(5):297-8. doi: 10.1056/NEJM198202043060511.
8
An assessment of clinically useful measures of the consequences of treatment.
N Engl J Med. 1988 Jun 30;318(26):1728-33. doi: 10.1056/NEJM198806303182605.
9
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
N Engl J Med. 1987 Jul 23;317(4):185-91. doi: 10.1056/NEJM198707233170401.
10
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Ann Intern Med. 1990 May 15;112(10):727-37. doi: 10.7326/0003-4819-112-10-727.
Zotero 插件